Warning: The NCBI web site requires JavaScript to function. more...
An official website of the United States government
The .gov means it's official. Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you're on a federal government site.
The site is secure. The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.
Integrated Metabolic Profiling and Gene Expression Analysis Reveals Therapeutic Modalities in Breast Cancer
PubMed Full text in PMC Similar studies
Expression data of patient-derived triple negative breast cancer xenograft tumors
PubMed Full text in PMC Similar studies Analyze with GEO2R
Separation of breast cancer and organ microenvironment transcriptomes in metastases
PubMed Full text in PMC Similar studies SRA Run Selector
Integrated molecular characterization of patient-derived models reveals therapeutic strategies for treating CIC-DUX4 sarcoma.
PubMed Full text in PMC Similar studies Analyze with GEO2RSRA Run Selector
Expression data from C3(1)Tag mammary tumors, tumor derived cell line (M6) and normal mammary tissue (FVB)
Expression of SV40 TAg signature in MDAMB231 cells, tumors, and normal human mammary epithelial cells (M98040 and M99005)
Genome-wide analysis of mRNA expression profile in MDA-MB-231 cells treated with or without 3.75 μM DCC-2036 for 48 hours.
PubMed Similar studies Analyze with GEO2R
The BET-bromodomain inhibitor OTX015 (MK-8628) exerts in vitro and in vivo anti-tumor activity in triple-negative breast cancer models as single agent and in combination with everolimus
Combination of epigenetic, differentiation and DNA damaging agents induce tumor cell death and stem cell depletion in breast cancer
A common cell state in Triple Negative Breast Cancers represents a druggable vulnerability
Interplay of choline metabolites and genes in patient-derived breast cancer xenografts
Subtype-specific response to bevacizumab is reflected in the metabolome and transcriptome of breast cancer xenografts
Changes of the gene expression profiling induced by fenofibrate
RNA-Seq Analysis of Anacardic Acid Treated MCF7 and MDA-MB-231 Breast Cancer Cell Lines
Efficacy of carboplatin alone and in combination with ABT888 in intracranial murine models of BRCA-mutated and BRCA-wild-type triple negative breast cancer
p53 deficiency linked to BTG2 loss enhances metastatic potential by promoting tumor growth in primary and metastatic sites in PDX models of triple negative breast cancer
Gene expression data from human breast cancer MDA-MB-231 cells treated with siRNAs targeting long non-coding RNA TMPO-AS1
Filters: Manage Filters
Your browsing activity is empty.
Activity recording is turned off.
Turn recording back on